Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 95.3% in January

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 1,400 shares, a decrease of 95.3% from the January 15th total of 29,500 shares. Based on an average trading volume of 107,000 shares, the short-interest ratio is currently 0.0 days.

Conduit Pharmaceuticals Stock Performance

Shares of NASDAQ CDTTW opened at $0.02 on Thursday. Conduit Pharmaceuticals has a 52 week low of $0.01 and a 52 week high of $0.15. The business has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.